REGENERON PHARMACEUTICALS INC earnings per share and revenue

RGO earnings per share for the last quarter are 10.96 CHF whereas the estimation was 10.25 CHF which accounts for 6.98% surprise. Company revenue for the same period amounts to 3.44 B CHF despite the estimated figure of 3.40 B CHF. Estimated earnings per share for the next quarter are 8.71 CHF, and revenue is expected to reach 3.13 B CHF. Also watch annual changes over time to get a bigger picture of RGO earnings per share and revenue dynamics.